Dr. Youssef M. Arshoun, MD

Dr. Arshoun practices at Allegheny Valley Hospital in Natrona, Pennsylvania, part of Highmark Health.

Dr. Arshoun's NPI, 1780683805, was assigned on July 20, 2005. Dr. Arshoun graduated from Ain Shams University Faculty of Medicine in 1987. Dr. Arshoun holds Pennsylvania license MD060402L.

Dr. Arshoun's primary practice is Allegheny Valley Hospital, at 1301 Carlisle St, Natrona, PA 15065 in Allegheny County. The practice phone is (412) 224-5100.

Dr. Arshoun's primary practice is Allegheny Valley Hospital in Natrona, Pennsylvania, part of Highmark Health. Dr. Arshoun is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Arshoun to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arshoun practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Arshoun's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Arshoun is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Arshoun's licenses on file in 4 states: Pennsylvania, Florida, Ohio and New Jersey.

Dmand AI lists bladder cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Arshoun treats.

CMS data shows 712 Medicare services from Dr. Arshoun across 11 procedure codes in 2024, for 102 Medicare patients. Medicare paid $44,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 102 Medicare patients who saw Dr. Arshoun in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arshoun's median patient age at 74, with 47% women.

In 2024, Dr. Arshoun wrote 83 Medicare Part D claims for 38 patients. 95% of them were for generic drugs. CMS names the drug for 54 of them, across 1 drug with 11 or more claims each, at $910 in total drug cost. In 2023, CMS named 72 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Arshoun for performance year 2024, reported through an alternative payment model (APM). Dr. Arshoun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Arshoun in 2012. Dr. Arshoun's most frequent co-authors are Ron R. Allison, MD, Richard John Carmel, MD and Steven E. Finkelstein, MD.

Dmand AI links Dr. Arshoun to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Oropharyngeal Neoplasms and Pharyngeal Neoplasms.

CMS Open Payments shows 65 general payments to Dr. Arshoun from 16 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 89% of the total. Bristol-Myers Squibb Company paid the most, $491.

Dr. Arshoun graduated from Ain Shams University Faculty of Medicine in 1987.

Dr. Arshoun is in network with 10 carriers, including Aetna, Elevance and Highmark. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.